Skip to main content
. 2021 Jul 8;69(4):2140–2147. doi: 10.1111/tbed.14208

TABLE 1.

Occurrence of SARS‐CoV‐2 antibodies in dogs and cats in Thailand by month (April 2020–December 2020)

Dog Cat
Month‐Year Sample ELISAa positive [suspected]/test (% positive) sVNTb positive/test (% positive) ELISAa positive [suspected]/test (% positive) sVNTb positive/test (% positive)
Apr‐20 504 4[3]/311 (1.29%) 0/7 1[1]/193 (0.52%) 0/2
May‐20 412 3[1]/213 (1.41%) 0/4 3[0]/199 (1.51%) 0/3
Jun‐20 NA NA NA NA NA
Jul‐20 459 6[2]/278 (2.16%) 0/8 0/181 0
Aug‐20 523 12[2]/374 (3.21%) 0/14 0/149 0
Sep‐20 581 5[0]/401 (1.25%) 0/5 0/180 0
Oct‐20 175 0/115 0 0/60 0
Nov‐20 175 2[1]/120 (1.67%) 0/3 0/55 0
Dec‐20 386 3[0]/291 (1.03%) 0/3 0[1]/95 0/1
3215 35[9]/2103 (1.66%) 0/44 4[2]/1112 (0.36%) 0/6

aIndirect ELISA: ID Screen® SARS‐CoV‐2 Double Antigen Multi‐species ELISA kit (ID VET, Montpellier, France). For the cut‐off values, S/P% > 60% is positive, S/P% 50−60% is suspect and < 50% is negative.

bsVNT: cPass™ SARS‐CoV‐2 Neutralization Antibody Detection Kit (GenScript Biotech, Jiangsu, China). The cut‐off values were defined as follows: positive of % inhibition > 20% and negative otherwise.